Skip to main content
. 2011 Jul 14;2:75–84. doi: 10.2147/OAJSM.S17048

Table 1.

Patient demographics and other baseline characteristics

Parametera,b DETP n = 138 Placebo n = 136 P value
Age (years) 34.5 ± 13.6
(18–65)
33.3 ± 12.3
(18–62)
0.42
Height (cm) 171.5 ± 8.9
(150–197)
170.0 ± 8.7
(143–188)
0.14
Weight (kg) 70.1 ± 12.8
(45–105)
67.4 ± 15.7
(38–168)
0.13
Body mass index (kg/m2) 23.8 ± 3.9
(16.9–39.4)
23.2 ± 4.2
(16.5–52.4)
0.23
Sex
 Male 79 (57%) 70 (51%) 0.34
 Female 59 (43%) 66 (49%)
Injury characteristics
Time to injury (hours) 17.7 ± 11.4
(1–48)
19.3 ± 11.7
(0.5–48)
0.28
Injury location
 Right ankle 84 (61%) 73 (54%) 0.26
 Left ankle 54 (39%) 62 (46%)
Swelling (mm)c 14.5 ± 10.6
(−10–50)
16.9 ± 11.0
(0–60)
0.09
Functional impairment, n (%)
 None 2 (1%) 3 (2%) 0.06
 Mild 39 (29%) 26 (19%)
 Moderate 62 (45%) 60 (44%)
 Severe 34 (25%) 47 (34%)
Leaning on single injured foot, n (%)
 Possible without pain 9 (7%) 10 (7%) 0.79
 Possible with pain 102 (74%) 96 (71%)
 Not possible 27 (19%) 30 (22%)
Skin examination
 Normal 134 (97%) 133 (98%) 0.72
 Abnormal (erythema/abrasion) 4 (3%) 3 (2%)
Mean pain score (VAS) (mm) 67.0 ± 10.6
(50–92)
69.3 ± 11.0
(50–100)
0.08

Notes:

a

Data were pooled from Study 1 and Study 2;

b

Mean ± standard deviation (ranges) for continuous variables; number of patients with percentage of total in parenthesis for categorical variables. P values derived from analysis of variance or the Chi-square test.

c

Difference in mm between the submalleolar perimeter of the injured and healthy ankle.

Abbreviations: DETP, diclofenac epolamine topical patch; VAS, visual analog scale.